Search Results - Later Yan

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial by Laman, M., Moore, Brioni, Benjamin, J., Yadi, G., Bona, C., Warrel, J., Kattenberg, J., Koleala, T., Manning, L., Kasian, B., Robinson, L., Sambale, N., Lorry, L., Karl, S., Davis, W., Rosanas-Urgell, A., Mueller, I., Siba, P., Betuela, I., Davis, T.

    Published 2014
    “…In this study, the efficacy, tolerability, and safety of these ACTs were assessed in PNG children aged 0.5–5 y.An open-label, randomized, parallel-group trial of artemether-lumefantrine (six doses over 3 d) and artemisinin-naphthoquine (three daily doses) was conducted between 28 March 2011 and 22 April 2013. …”
    Get full text